10/30
10:47 am
ipha
Innate Pharma (NASDAQ:IPHA) was upgraded by analysts at HC Wainwright from a "hold" rating to a "strong-buy" rating.
Low
Report
Innate Pharma (NASDAQ:IPHA) was upgraded by analysts at HC Wainwright from a "hold" rating to a "strong-buy" rating.
10/29
08:08 am
ipha
Innate Pharma (NASDAQ:IPHA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
Report
Innate Pharma (NASDAQ:IPHA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
10/29
06:09 am
ipha
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
Low
Report
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
10/29
06:09 am
ipha
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
Low
Report
Innate Pharma upgraded to Buy from Neutral at H.C. Wainwright
10/29
05:27 am
ipha
Rating for IPHA
Low
Report
Rating for IPHA